1. Home
  2. PAHC vs EFC Comparison

PAHC vs EFC Comparison

Compare PAHC & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$38.24

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

EFC

Ellington Financial Inc.

HOLD

Current Price

$13.58

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
EFC
Founded
1946
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
PAHC
EFC
Price
$38.24
$13.58
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$31.25
$14.46
AVG Volume (30 Days)
298.0K
1.4M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
1.25%
11.49%
EPS Growth
288.74
1.22
EPS
1.67
1.33
Revenue
$1,399,676,000.00
$329,815,000.00
Revenue This Year
$15.34
N/A
Revenue Next Year
$3.28
$8.81
P/E Ratio
$23.08
$10.19
Revenue Growth
33.72
13.84
52 Week Low
$16.16
$11.12
52 Week High
$46.42
$14.40

Technical Indicators

Market Signals
Indicator
PAHC
EFC
Relative Strength Index (RSI) 38.28 47.78
Support Level $38.27 $13.59
Resistance Level $41.94 $13.77
Average True Range (ATR) 1.91 0.18
MACD -0.57 -0.02
Stochastic Oscillator 1.94 36.49

Price Performance

Historical Comparison
PAHC
EFC

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: